[Advances in the treatment of advanced colorectal cancer].
Díaz-Rubio
E
E
Servicio de Oncología Médica, Hospital Universitario San Carlos, Madrid.
D000963:Antimetabolites / Q000378:metabolism / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000378:metabolism / Q000627:therapeutic use*; D002945:Cisplatin / Q000378:metabolism / Q000627:therapeutic use; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology / Q000628:therapy; D004347:Drug Interactions; D005472:Fluorouracil / Q000378:metabolism / Q000627:therapeutic use; D006801:Humans; D007372:Interferons / Q000378:metabolism / Q000627:therapeutic use; D007376:Interleukin-2 / Q000378:metabolism / Q000627:therapeutic use; D002955:Leucovorin / Q000378:metabolism / Q000627:therapeutic use; D008727:Methotrexate / Q000378:metabolism / Q000627:therapeutic use; D009367:Neoplasm Staging; D011687:Purines / Q000378:metabolism / Q000627:therapeutic use
D000963:Antimetabolites; D007376:Interleukin-2; D011687:Purines; D007372:Interferons; D002945:Cisplatin; D002955:Leucovorin; D005472:Fluorouracil; D008727:Methotrexate
Avances en el tratamiento del cáncer colorrectal avanzado.